Fund profile · Compiled from public sources

BOLD Longevity Growth

Boston, USA · Series B → Growth

Their stated focus (public profile)

BOLD Longevity Growth is a global longevity fund investing in frontier biotechnologies that target the root causes of aging and age-related diseases. The fund focuses on growth-stage (Series B+) platform technologies at the intersection of longevity, biotech, and artificial intelligence, targeting 3–5 year exits. It co-invests with large biotech VC funds and big pharma, backing companies in gene therapies, cell therapies, AI drug discovery, early diagnostics, and AI-powered medtech with the mission of making longevity technologies affordable and accessible.

Stages: Series B → Growth

Sectors: Longevity, Life sciences, AI / ML, Editing, Biosensing, Biowearables

On file: 10 companies on record

Website: blg.vc

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →